Patient Support Programs-New EU Regulations and its Challenges for Pharmaceutical Companies

被引：0

作者：

Oberender, H. A. ^{[1
]}

Koelm, P. ^{[2
]}

机构：

[1] Bayer Pharma AG, Global Pharmacovigilance, Wuppertal, Germany

[2] Bayer Pharma AG, Global Pharmacovigilance, Berlin, Germany

来源：

DRUG SAFETY | 2013年 / 36卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：940 / 941

页数：2

共 17 条

[1] HOW AWARE ARE BIOTECH AND PHARMACEUTICAL COMPANIES OF THE IMPLEMENTATION OF THE NEW EU HTA?
Bean, S.
Foxon, G.
Hewitt, C.
VALUE IN HEALTH, 2023, 26 (12) : S392 - S392
[2] Challenges Posed on The New Mining Act and Its Regulations in Tanzania
Marwa, Charles W.
Warioba, Isabela
JOURNAL OF POLITICS AND LAW, 2015, 8 (04) : 185 - 190
[3] Clinical Trials, Data Protection and Patient Empowerment in the Era of the New EU Regulations
Negrouk, Anastassia
Horgan, Denis
Gorini, Alessandra
Cutica, Ilaria
Leyense, Lada
Halfmann, Sebastian Schee Genannt
Pravettoni, Gabriella
PUBLIC HEALTH GENOMICS, 2015, 18 (06) : 386 - 395
[4] PATIENT-CENTRICITY FOR PHARMACEUTICAL COMPANIES: NEW MODELS IN THE ERA OF CONNECTED HEALTH
Rahardjani, M.
Pacheco, L.
VALUE IN HEALTH, 2019, 22 : S811 - S812
[5] New CMS Clinical Decision Support Regulations: A Potential Opportunity with Major Challenges
Hentel, Keith
Menard, Andrew
Khorasani, Ramin
RADIOLOGY, 2017, 283 (01) : 10 - 13
[6] REDUCING INEQUITY: DOES THE NEW EU PHARMACEUTICAL LEGISLATION ADDRESS CHALLENGES TO PHARMACEUTICAL ACCESS IN CENTRAL AND EASTERN EUROPE?
Stringfellow, N.
VALUE IN HEALTH, 2023, 26 (12) : S269 - S269
[7] BRIDGING THE PRACTICE TO THEORY GAP: UNCOVERING AND ADDRESSING BARRIERS AND FACILITATORS TO EVALUATION OF PATIENT SUPPORT PROGRAMS BY THE PHARMACEUTICAL INDUSTRY
Moloney, C.
Walburn, J.
VALUE IN HEALTH, 2023, 26 (12) : S490 - S490
[8] Financial support provided to male and female physicians by pharmaceutical companies in New Zealand: a cross-sectional study
Jones, Leah
MEDICAL JOURNAL OF AUSTRALIA, 2023, 219 (06) : 275 - 277
[9] ECHA doubles the number of trainees as the first step of its new graduate scheme for EU chemicals regulations
不详
ANTI-CORROSION METHODS AND MATERIALS, 2012, 59 (02) : 89 - 90
[10] Fewer new drugs from the pharmaceutical industry - A better understanding of the economic challenges facing research based companies is needed
Taylor, D
BRITISH MEDICAL JOURNAL, 2003, 326 (7386): : 408 - 409

← 1 2 →